Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism

Autor: Brianne S Thicke, Ming Ruan, Aleksey V. Matveyenko, Jennifer R. Geske, Merry Jo Oursler, Amanda J Tweed, David G. Monroe, Bart L. Clarke, Brittany A. Eckhardt, Thomas Levin Andersen, Joshua N. Farr, Chee Kian Chew, Matthew T. Drake, Sundeep Khosla, Adrian Vella, Robert A. Rizza, Elizabeth J. Atkinson, Moustapha Kassem, Louise K. McCready, Megan M. Weivoda
Rok vydání: 2019
Předmět:
0301 basic medicine
General Physics and Astronomy
Osteoclasts
Bone remodeling
0302 clinical medicine
Glucose homeostasis
Prospective Studies
lcsh:Science
Aged
80 and over

Multidisciplinary
Osteoblast
Middle Aged
Resorption
medicine.anatomical_structure
Denosumab
Female
Bone Remodeling
medicine.drug
musculoskeletal diseases
medicine.medical_specialty
Science
Dipeptidyl Peptidase 4
education
chemistry.chemical_element
030209 endocrinology & metabolism
Calcium
General Biochemistry
Genetics and Molecular Biology

Bone resorption
Bone and Bones
Article
03 medical and health sciences
Osteoclast
Internal medicine
medicine
Animals
Humans
Bone
Aged
Osteoblasts
Tumor Suppressor Proteins
Calcium-Binding Proteins
General Chemistry
Repressor Proteins
030104 developmental biology
Endocrinology
chemistry
Diabetes Mellitus
Type 2

Osteoporosis
lcsh:Q
Energy Metabolism
Zdroj: Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
Weivoda, M M, Chew, C K, Monroe, D G, Farr, J N, Atkinson, E J, Geske, J R, Eckhardt, B, Thicke, B, Ruan, M, Tweed, A J, McCready, L K, Rizza, R A, Matveyenko, A, Kassem, M, Andersen, T L, Vella, A, Drake, M T, Clarke, B L, Oursler, M J & Khosla, S 2020, ' Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism ', Nature Communications, vol. 11, 87 . https://doi.org/10.1038/s41467-019-14003-6
ISSN: 2041-1723
Popis: Bone remodeling consists of resorption by osteoclasts followed by formation by osteoblasts, and osteoclasts are a source of bone formation-stimulating factors. Here we utilize osteoclast ablation by denosumab (DMAb) and RNA-sequencing of bone biopsies from postmenopausal women to identify osteoclast-secreted factors suppressed by DMAb. Based on these analyses, LIF, CREG2, CST3, CCBE1, and DPP4 are likely osteoclast-derived coupling factors in humans. Given the role of Dipeptidyl Peptidase-4 (DPP4) in glucose homeostasis, we further demonstrate that DMAb-treated participants have a significant reduction in circulating DPP4 and increase in Glucagon-like peptide (GLP)-1 levels as compared to the placebo-treated group, and also that type 2 diabetic patients treated with DMAb show significant reductions in HbA1c as compared to patients treated either with bisphosphonates or calcium and vitamin D. Thus, our results identify several coupling factors in humans and uncover osteoclast-derived DPP4 as a potential link between bone remodeling and energy metabolism.
Anti-resorptive bone therapies also inhibit bone formation, as osteoclasts secrete factors that stimulate bone formation by osteoblasts. Here, the authors identify osteoclast-secreted factors that couple bone resorption to bone formation in healthy subjects, and show that osteoclast-derived DPP4 may be a factor coupling bone resorption to energy metabolism.
Databáze: OpenAIRE